UPL Limited has informed the Exchange regarding 'We would like to inform you that UPL Ltd had made an announcement to the stock exchangeon 20 July 2018 for acquisition ("Transaction") of 100% shares of Arysta LifeScience Inc.and its subsidiaries from Platform Speciality Products Corporation, an entity listed in theUnited States of America and further announcement on January 24, 2019 informing that allregulatory approvals necessary to complete the Transaction have been obtained and that theTransaction is expected to close on 31 January 2019. This acquisition has been made throughUPL Corporation Ltd, the international arm of UPL Ltd.Now we would like to inform that the Transaction has closed on January 31, 2019.May we request you to take the same on your record and inform all your constituentsaccordingly.'.